Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019
Cash flows from operating activities:
Net loss	$ (767,591)	$ (3,707,685)
Adjustments to reconcile net loss to net cash used in operating activities
Stock-based compensation	200,114	476,458
Depreciation and amortization	1,023,757	798,206
Deferred income tax benefit		(699,000)
Recovery on contingent earnout		(200,000)
Bad debt expense	120,160
(Increase)/decrease in operating assets
Accounts receivable	752,463	993,042
Contract assets	(480,889)	(1,229,987)
Inventories	264,978	92,658
Tax receivable	(713,027)
Other current assets	315,649	411,690
Other assets		29,635
Increase/(decrease) in operating liabilities
Accounts payable	(94,994)	317,881
Accrued expenses	(397,546)	203,205
Contract liabilities	(759,919)	(393,191)
Deferred revenue	(651,659)	814,126
Total adjustments	(420,913)	1,614,723
Net cash used in operating activities	(1,188,504)	(2,092,962)
Cash flows from investing activities:
Capital expenditures	(1,202,899)	(2,115,733)
Net cash used in investing activities	(1,202,899)	(2,115,733)
Cash flows from financing activities
Proceeds from Payroll Protection Plan Loan	2,415,970
Payments of long-term debt	(501,323)	(491,601)
Net cash provided by (used) in financing activities	1,914,647	(491,601)
Net decrease in cash and cash equivalents	(476,756)	(4,700,296)
Cash and cash equivalents at beginning of period	8,664,253	11,439,361
Cash and cash equivalents at end of period	8,187,497	6,739,065
Supplemental disclosure of cash flow information:
Income taxes paid
Interest paid	336,107	365,255
Supplemental disclosure of non-cash investing and financing activities:
Capitalization of right to use Asset		$ 103,937